Repeatability and reproducibility of a handheld quantitative G6PD diagnostic
Authors:
- Benedikt LeyBenedikt Ley
- Ari Winasti SatyagrahaASAri Winasti Satyagraha
- Mohammad Golam KibriaMKMohammad Golam Kibria
- Jillian ArmstrongJAJillian Armstrong
- Germana BanconeGBGermana Bancone
- Greg BiziljGBGreg Bizilj
- Marcelo BritoMBMarcelo Brito
- Gonzalo J. DomingoGDGonzalo J. Domingo
- Michael E. von FrickenMFMichael E. von Fricken
Open Access
- 17 February 2022
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 16 (2) , e0010174
Abstract
Background: The introduction of novel short course treatment regimens for the radical cure of Plasmodium vivax requires reliable point-of-care diagnosis that can identify glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. While deficient males can be identified using a qualitative diagnostic test, the genetic make-up of females requires a quantitative measurement. SD Biosensor (Republic of Korea) has developed a handheld quantitative G6PD diagnostic (STANDARD G6PD test), that has approximately 90% accuracy in field studies for identifying individuals with intermediate or severe deficiency. The device can only be considered for routine care if precision of the assay is high. Methods and findings: Commercial lyophilised controls (ACS Analytics, USA) with high, intermediate, and low G6PD activities were assessed 20 times on 10 Biosensor devices and compared to spectrophotometry (Pointe Scientific, USA). Each device was then dispatched to one of 10 different laboratories with a standard set of the controls. Each control was tested 40 times at each laboratory by a single user and compared to spectrophotometry results. When tested at one site, the mean coefficient of variation (CV) was 0.111, 0.172 and 0.260 for high, intermediate, and low controls across all devices respectively; combined G6PD Biosensor readings correlated well with spectrophotometry (rs = 0.859, ps = 0.604, p<0.001) and G6PD activity determined by Biosensor for the low and intermediate controls overlapped. The use of lyophilised human blood samples rather than fresh blood may have affected these findings. Biosensor G6PD readings between sites did not differ significantly (p = 0.436), whereas spectrophotometry readings differed markedly between sites (p<0.001). Conclusions: Repeatability and inter-laboratory reproducibility of the Biosensor were good; though the device did not reliably discriminate between intermediate and low G6PD activities of the lyophilized specimens. Clinical studies are now required to assess the devices performance in practice.Keywords
Funding Information
- Department of Foreign Affairs and Trade, Australian Government
- Wellcome Trust (200909)
- Wellcome Trust (220211)
- Wellcome Trust (220211)
This publication has 23 references indexed in Scilit:
- Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working GroupMalaria Journal, 2018
- Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countriesPLOS Neglected Tropical Diseases, 2018
- Primaquine-induced haemolysis in females heterozygous for G6PD deficiencyMalaria Journal, 2018
- Antimicrobial resistance patterns and virulence factors of enterococci isolates in hospitalized burn patientsBMC Research Notes, 2018
- The challenges of introducing routine G6PD testing into radical cure: a workshop reportMalaria Journal, 2015
- G6PD Deficiency at Sumba in Eastern Indonesia Is Prevalent, Diverse and Severe: Implications for Primaquine Therapy against Relapsing Vivax MalariaPLOS Neglected Tropical Diseases, 2015
- G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD testsMalaria Journal, 2013
- G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based MapPLOS Medicine, 2012
- The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysisBlood Cells, Molecules, and Diseases, 2009
- Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group.1989